|

Results of Surgical Treatment of the Hepatobiliopancreatic Surgical Unit

RECRUITINGSponsored by Fundacion Miguel Servet
Actively Recruiting
SponsorFundacion Miguel Servet
Started2019-01-03
Est. completion2024-01
Eligibility
Age15 Years – 90 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04556019

Summary

The main aims of this study are: 1. \- to evaluate post-surgical morbidity and mortality outcomes, following the criteria and the definitions from Claven-Dindo and ISGPS international classifications, of the patients operated by the HPB Surgical Unit. 2. \- to evaluate survival and disease-free survival rates of the patients operated by the HPB Surgical Unit due to tumoral cause.

Eligibility

Age: 15 Years – 90 YearsHealthy volunteers accepted
Inclusion Criteria:

* All patients operated by the HPB Surgical Unit in the last 10 years (retrospective)
* All patients being operated by the HPB Surgical Unit from January 2019 onwards who provide inform consent (prospective).

Exclusion Criteria:

* Patients not eligible for surgery
* Patients not interested in taking part in the study

Conditions5

Bile Duct DiseasesLiver DiseaseLiver DiseasesPancreas DiseaseSurgical Procedure, Unspecified

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.